Skip to main content
Decorative image of the AMR Learning Lounge

Pharmacists Can Make a Difference in Antibiotic Stewardship at Discharge

SUMMARY

Infectious Disease (ID) pharmacists can play a key role in optimizing antibiotic use beyond hospital doors through stewardship initiatives targeting transition of care. Authors share data from an Annals of Pharmacotherapy study showing that, of the patient cases they reviewed, ID pharmacists identified drug-related problems in more than 40% of oral antibiotic prescriptions delivered at discharge. It is estimated that up to 70% of antibiotic courses prescribed at discharge could be improved through narrowing the antibiotic spectrum, proper dosing, reducing duration, or stopping antibiotics altogether. 

FEATURED EXPERTS 

Corey J. Medler, PharmD, MPH, BCIDP, ID Pharmacist at UVA Health, Virginia 

Allison M. Field, PharmD, AAHIVP, ID Pharmacist at ECU Health, North Carolina


GET STARTED

Read the editorial at Pharmacy Times

Estimated reading time: 6 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


GLOBAL Solutions

VIDAS® B•R•A•H•M•S PCT™

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

U.S. bioMérieux Solutions

US Solutions

VIDAS® B•R•A•H•M•S PCT™

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

PUBLISHED BY

Pharmacy Times

July 18, 2023


SHARE THIS ARTICLE: